| Dr Joseph Hamati, MD | |
|
1800 S Douglas Blvd, Midwest City, OK 73130-6224 | |
| (405) 741-7722 | |
| Not Available |
| Full Name | Dr Joseph Hamati |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 9 Years |
| Location | 1800 S Douglas Blvd, Midwest City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033599410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 31413 (Oklahoma) | Secondary |
| 207L00000X | Anesthesiology | 31413 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alliancehealth Midwest | Midwest city, OK | Hospital |
| Ssm Health St Anthony Hospital - Oklahoma City | Oklahoma city, OK | Hospital |
| Ssm Health St Anthony Hospital - Shawnee | Shawnee, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Medical Group, Llc | 7012914898 | 298 |
News Archive
IMS Health reported today that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion over the next five years, reaching $1.1 trillion in 2014. The 5 - 8 percent compound annual growth rate during this period reflects the impact of leading products losing patent protection in developed markets, as well as strong overall growth in the world's emerging countries.
In laboratory tests in dogs, cardiac researchers at Washington University School of Medicine in St. Louis have found that treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation. They report their findings in the June 7 issue of Circulation.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015.
› Verified 4 days ago
| Entity Name | Saint Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437195922 PECOS PAC ID: 7012914898 Enrollment ID: O20061109000189 |
News Archive
IMS Health reported today that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion over the next five years, reaching $1.1 trillion in 2014. The 5 - 8 percent compound annual growth rate during this period reflects the impact of leading products losing patent protection in developed markets, as well as strong overall growth in the world's emerging countries.
In laboratory tests in dogs, cardiac researchers at Washington University School of Medicine in St. Louis have found that treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation. They report their findings in the June 7 issue of Circulation.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015.
› Verified 4 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
IMS Health reported today that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion over the next five years, reaching $1.1 trillion in 2014. The 5 - 8 percent compound annual growth rate during this period reflects the impact of leading products losing patent protection in developed markets, as well as strong overall growth in the world's emerging countries.
In laboratory tests in dogs, cardiac researchers at Washington University School of Medicine in St. Louis have found that treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation. They report their findings in the June 7 issue of Circulation.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Hamati, MD 1800 S Douglas Blvd, Midwest City, OK 73130-6224 Ph: () - | Dr Joseph Hamati, MD 1800 S Douglas Blvd, Midwest City, OK 73130-6224 Ph: (405) 741-7722 |
News Archive
IMS Health reported today that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion over the next five years, reaching $1.1 trillion in 2014. The 5 - 8 percent compound annual growth rate during this period reflects the impact of leading products losing patent protection in developed markets, as well as strong overall growth in the world's emerging countries.
In laboratory tests in dogs, cardiac researchers at Washington University School of Medicine in St. Louis have found that treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation. They report their findings in the June 7 issue of Circulation.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015.
› Verified 4 days ago
John Kevin Mirjanich, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Parklawn Dr, Midwest City, OK 73110 Phone: 405-360-7576 Fax: 405-360-7762 | |
Dr. Xiangyang Zheng, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Parklawn Dr, Midwest City, OK 73110 Phone: 405-610-4411 Fax: 405-843-2077 | |
Vernon Clifford Hofmann, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2825 Parklawn Dr, Midwest City, OK 73110 Phone: 405-360-7576 Fax: 405-360-7762 |